Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Flow Nasal Cannula Versus Non-Invasive (NIV)in Both Hypoxemic and Hypercapnic Respiratory Failure.

NCT05499039 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05499039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05499039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Flow Nasal Cannula Versus Non-Invasive (NIV)in Both Hypoxemic and Hypercapnic Respiratory Failure.
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2022
Completion date
October 20, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypercapnic respiratory failure, acute hypoxemic respiratory failure